The PERSISTENT trial: A prospective randomized trial comparing insulin lispro protamine suspension to insulin glargine in patients with type 2 diabetes on anti-hyperglycemic medications.

Trial Profile

The PERSISTENT trial: A prospective randomized trial comparing insulin lispro protamine suspension to insulin glargine in patients with type 2 diabetes on anti-hyperglycemic medications.

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Jun 2015

At a glance

  • Drugs Insulin neutral protamine lispro (Primary) ; Insulin glargine
  • Indications Type 2 diabetes mellitus
  • Focus Registrational; Therapeutic Use
  • Acronyms PERSISTENT
  • Sponsors Eli Lilly
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 23 Jun 2012 Planned number of patients changed from 482 to 511 as reported by European Clinical Trials Database.
    • 01 Oct 2010 Primary endpoint 'Proportion of glycosylated haemoglobin' has been met according to results published in Diabetes, Obesity and Metabolism.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top